Works by Shi, Yingqi


Results: 15
    1
    2

    Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial.

    Published in:
    JAMA Neurology, 2021, v. 78, n. 3, p. 293, doi. 10.1001/jamaneurol.2020.4857
    By:
    • Sperling, Reisa;
    • Henley, David;
    • Aisen, Paul S.;
    • Raman, Rema;
    • Donohue, Michael C.;
    • Ernstrom, Karin;
    • Rafii, Michael S.;
    • Streffer, Johannes;
    • Shi, Yingqi;
    • Karcher, Keith;
    • Raghavan, Nandini;
    • Tymofyeyev, Yevgen;
    • Bogert, Jennifer;
    • Brashear, H. Robert;
    • Novak, Gerald;
    • Thipphawong, John;
    • Saad, Ziad S.;
    • Kolb, Hartmuth;
    • Rofael, Hany;
    • Sanga, Panna
    Publication type:
    Article
    3
    4
    5
    6
    7

    Tribracket Modules.

    Published in:
    International Journal of Mathematics, 2020, v. 31, n. 4, p. N.PAG, doi. 10.1142/S0129167X20500287
    By:
    • Needell, Deanna;
    • Nelson, Sam;
    • Shi, Yingqi
    Publication type:
    Article
    8
    9
    10
    11
    12

    FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P873, doi. 10.1016/j.jalz.2019.06.4621
    By:
    • Henley, David;
    • Sperling, Reisa A.;
    • Aisen, Paul S.;
    • Raman, Rema;
    • Donohue, Michael C.;
    • Ernstrom, Karin;
    • Shi, Yingqi;
    • Karcher, Keith;
    • Raghavan, Nandini;
    • Tymofyeyev, Yevgen;
    • Brashear, Robert;
    • Novak, Gerald P.;
    • Thipphawong, John;
    • Saad, Ziad;
    • Kolb, Hartmuth C.;
    • Romano, Gary
    Publication type:
    Article
    13
    14
    15